BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Pulmatrix 

99 Hayden Avenue
Suite 390
Lexington  Massachusetts  02421  U.S.A.
Phone: 781-357-2333 Fax: 781-357-2399


SEARCH JOBS




Industry
Biotechnology






 Company News
Pulmatrix Announces Positive Results From Initial Stage of Phase IB Clinical Study of PUR0200 in COPD Patients 10/28/2013 10:42:33 AM    More...
Quotient Clinical Announces RapidFACT Collaboration With Pulmatrix to Develop a New Bronchodilator Therapy for COPD 8/13/2013 8:59:43 AM    More...
Pulmatrix Announces Initiation of Phase IB Clinical Study of PUR0200 in COPD 7/22/2013 9:38:35 AM    More...
Cystic Fibrosis Foundation Therapeutics, Inc. and Pulmatrix Initiate Collaboration to Accelerate PUR118 in the Treatment of Cystic Fibrosis 9/14/2012 9:05:27 AM    More...
Quotient and Pulmatrix Announce Completion of Innovative COPD Proof-of-Concept Clinical Program 9/4/2012 12:41:21 PM    More...
Pulmatrix Taps Robert Clarke, Ph.D. CEO, Releases Promising Data on Lung Drug 9/4/2012 7:34:14 AM    More...
Pulmatrix Announces Presentations at European Respiratory Society Annual Congress for Lead Inhaled iCALM Drug Candidate, PUR118 8/27/2012 10:13:24 AM    More...
Pulmatrix Announces Presentation of Clinical Data Demonstrating iCALM Inhaled Therapeutic Reduced Airway Inflammation 5/22/2012 10:58:17 AM    More...
Pulmatrix Announces Presentations at ATS 2012 International Conference 5/16/2012 10:15:11 AM    More...
Pulmatrix Demonstrates iSPERSE Capabilities for Inhaled Dry Powder Delivery of Antibiotics and Antibodies 5/15/2012 10:14:13 AM    More...
123